Brightpearl, the leading multichannel retail management platform, today announced integration with M2E Pro to provide complete and cohesive Product Publishing from Magento to Amazon, eBay, and...

Today in Barcelona, Spain Unify, the Atos brand for communications and collaboration software and services, kicked off its annual global Partner Conference, bringing together over 250 partners...

New research presented this week at Experimental Biology 2016 (EB 2016) expands on the current body of evidence supporting the link between dried plums (prunes) and bone health in post-menopausal...

Diebold, Incorporated (NYSE: DBD) is showcasing one of its newest mobile-driven banking concepts, along with an industry-leading security application from Cryptera, at Money 20/20 Europe....

BIGaVu, LLC, a San Diego, CA start-up, today announced that it will be unveiling prototypes of its IoT focused "smart comfort device" that utilize its proprietary technology in Laguna Niguel, CA...

Stealth BioTherapeutics (Stealth), a clinical-stage biopharmaceutical company developing investigational drugs for treating mitochondrial dysfunction, announced promising results from the Phase 1...

Findings from a clinical trial comparing Victoza® (liraglutide [rDNA origin] injection) and sitagliptin (100 mg), both in combination with metformin, demonstrated that switching from sitagliptin...

Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, announced findings from two new studies demonstrating the clinical utility of the Afirma...

Findings from the first phase 3a clinical trial for semaglutide, an investigational glucagon-like peptide-1 (GLP-1) analogue, demonstrated that treatment with semaglutide, administered once...

Boehringer Ingelheim Pharmaceuticals, Inc. today announced the results of a new interim analysis of data from the ongoing phase III RE-VERSE AD™ patient study that showed a single 5g dose of...